Dysmenorrhea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18 and 45 years; medical diagnosis of primary dysmenorrhea according to Guideline Nº 34539; mean pain equal to or greater than 4 on the Visual Analogue Scale of Pain; periodic pain of at least 3 menstrual cycles in a row; having a regular menstrual cycle of 28 to 32 days; no pelvic inflammatory disease; history of head trauma; epilepsy; endometriosis; current pregnancy; chronic abdominal pain unrelated to the menstrual cycle; fibroids; inflammatory bowel syndrome; irritable bowel syndrome; major abdominal or pelvic surgery; alcohol dependence; nicotine or drugs; metallic implant; pacemaker; and chronic urinary tract disease
Exclusion criteria
Exclusion criteria: Severe headache in more than two transcranial stimulation sessions; dizziness or severe migraine in more than two transcranial stimulation sessions; failure to perform 2 or more transcranial stimulation applications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is a main primary outcome that is expected to find a improvement of 30% in pain determined through the visual analogue scale according to pre and post intervention;Improvement of 20% of theta band oscillation measured through electroencephalography according to pre and post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected to find 30% improvement in pressure pain threshold and tolerance using a pressure algometer according to pre and post intervention;It is expected to find a improvement of 30% of the intensity and interference of pain through the pain inventory according to pre and post intervention;It is expected a 30% of improvement in the submaximal functional capacity assessed through the 6-minute walk test on pre intervention and post intervention;It is expected an improvement of 20% in lower limb strength assessed using the 30-second sit-to-stand test according to pre and post intervention;It is expected an improvement of 20% in power, speed, agility and dynamic balance is expected according to the Timed Up and Go test according to pre and post intervention;It is expected an improvement of 30% is expected in quality of life assessed by the short version of the World Health Organization Quality of Life questionnaire according to pre and post intervention;A moderate improvement of up to 30% is expected in positive and negative affect assessed by the affect scale according to pre and post intervention;A moderate improvement of up to 30% is expected in anxiety measured according to the Hamilton Anxiety Scale according to pre and post intervention;A moderate improvement of up to 30% is expected in depression measured according to the Beck Depression Scale according to pre and post intervention;Improvement of 30% in symptoms related to primary dysmenorrhea as assessed by the Premenstrual Symptom Screening Tool and the Somatic Symptom Scale-8 according to pre and post intervention | — |
Countries
Brazil
Contacts
Universidade Federal do Rio Grande do Norte